All posts by imreal

New Book Features Walmart’s History in Healthcare


As retailers rush to fill their stores with medical services, Walmart’s three-decade history in healthcare from Sam Walton’s vision to control costs to today’s doctor-staffed Walmart Health “super centers” are featured in a new book: “Walmart’s Second Opinion.”

Published by Validation Institute, “Walmart’s Second Opinion: How a Retail Giant is Bringing Cost Transparency and Better Quality to Healthcare,” explores the pivotal moments and strategies that have enabled Walmart to redefine the retailing of healthcare, starting with the Walmart founder’s desire to solve the company’s escalating healthcare costs while striving to enhance the quality of care for employees.

“Though retailers and others are grabbing a lot of attention spending billions of dollars in recent years to enter the prescription drug and primary care business, the reality is that Walmart has been an innovator and disruptor in the healthcare business for more than 30 years,” says Vidar J. Jorgensen, Chairman of Validation Institute. “This book outlines not only Walmart’s history as a provider and payer of healthcare services, but the kind of progress Sam Walton wanted to see when he approached Tom Emerick in 1991 for ideas on how to control costs while improving quality for employees.”

Mr. Emerick will be inducted into the Validation Institute Hall of Fame this Tuesday, June 20, at The Healthcare Innovation Congress (thINc360) in Washington, D.C. for his work in developing the Walmart Centers of Excellence program that enables Walmart employees and a partner to go to the best health care providers in the US at no cost to the employee.

Though Walmart is best known for its prowess as a big box retailer offering everything from general merchandise to groceries, its healthcare services and benefits for employees have become models and copied across the country. The book outlines how Walmart partnered with “Centers of Excellence” such as the Mayo Clinic, Cleveland Clinic, and Geisinger Health System more than 20 years ago to ensure that employees received high quality medical care treatment that was done right the first time. Such covered services — ranging from heart and spine surgery to cancer and fertility care — were good for the worker, but were also beneficial for Walmart because it assured that the employee would receive the highest quality healthcare and return to the workforce more quickly.

These days, Walmart is expanding mental health services for employees and customers while adding behavioral care to the dental services and outpatient primary care at its Walmart Health brand centers that treat consumers across the country. Such facilities are projected to double by the end of 2024.

About the Authors

The book is written by Forbes senior contributor and national healthcare writer Bruce Japsen, who has followed Walmart and the business of healthcare for 30 years, and award-winning medical science writer and market analyst Malorye Allison Branca, who has been reporting on healthcare topics for over 20 years.

About Validation Institute

Validation Institute provides unbiased, data-driven insights on health care solutions and services by validating performance claims made by solutions providers and educating purchasers to drive transparency in the marketplace and maximize cost-savings.

Press Contact:

Reena Joseph

Director, Marketing and Partnerships

Validation Institute

1-781-939-2446

Reena.Joseph@validationinstitute.com

Share article on social media or email:

MTI/ASPS Plastic Surgery Accelerator propels five plastic surgery startups to finals of annual medtech competition


Five plastic surgery track startups selected to advance in joint effort between the American Society of Plastic Surgeons (ASPS) and MedTech Innovator (MTI).

“Plastic surgery thrives on innovation and attracts creative, entrepreneurial individuals who are constantly striving to improve outcomes and safety for patients,” says ASPS President Gregory Greco, DO, FACS, Red Bank, N.J.

Five plastic surgery startups advanced through a rigorous selection process to represent the MTI/ASPS Plastic Surgery Accelerator track in the 2023 MedTech Innovator Accelerator program and competition. Each startup will take part in the comprehensive program, designed to help grow promising new companies focused on medical device, diagnostic and digital health technology.

The plastic surgery track startups selected to advance in this joint effort between the American Society of Plastic Surgeons (ASPS) and MedTech Innovator (MTI) include 4th Dimension EMR (San Diego, Calif.), Cellulora (Philadelphia), Fingy 3D (Morgantown, W.Va.), ImmersiveTouch (Chicago) and Newrotex (Oxford, U.K.). The five finalists join a field of 61 startups from around the world that will compete for a share of $800,000 in funding awards over the course of the four-month program.

“Plastic surgery thrives on innovation and attracts creative, entrepreneurial individuals who are constantly striving to improve outcomes and safety for patients,” says ASPS President Gregory Greco, DO, FACS, Red Bank, N.J. “This program provides enormous value to ASPS members looking to bring their ideas to market – but it also advances the specialty and, most importantly, holds the potential to improve care worldwide.”

More than 70 companies entered the MTI/ASPS Plastic Surgery Accelerator competition this year, and 12 advanced to the live-pitch judging phase, where the top five were selected to represent the plastic surgery track. The size of this year’s ASPS cohort increased from last year’s inaugural group of three finalist startups; this first plastic surgery track cohort was very successful, placing companies in all three finals of the MTI program’s internal competitions.

ASPS participation in the MTI/ASPS Plastic Surgery Accelerator is made possible through the generous support of Motiva, the Society’s 2023 Innovation Sponsor. Each of the five cohort participants from the MTI/ASPS Plastic Surgery Accelerator will be featured at Plastic Surgery The Meeting, Oct. 26-29 in Austin, Texas, and receive mentoring from ASPS surgeons and associated entrepreneurs. They will also participate in MedTech Innovator’s corporate mentorship program, where they will be matched with senior industry leaders to receive ongoing in-depth, customized mentorship and support.

“We are proud of our stellar track record of identifying and perfecting the most innovative medtech startups in the world,” says Paul Grand, CEO and founder of MedTech Innovator. “The 2023 MedTech Innovator Cohort once again includes passionate medtech entrepreneurs from around the globe. We look forward to working with our corporate partners and industry advisors over the course of the program, to help these startups advance their medical device, diagnostic and digital health innovations to improve patient care.”

This year’s event marks the second year of the ASPS/MTI partnership, but since the launch of MedTech Innovator in 2013, more than 500 companies completed the program, resulting in more than 200 FDA approvals and clearances, and $6.8 billion in funding.

The 2023 accelerator program launches June 14-15 at the MedTech Innovator Summit in Mountain View, Calif. Leadership teams from each of the 61 startups will attend networking events and workshops with MedTech Innovator partners, alumni and industry leaders.

The 2023 cohort will then be featured June 16 at the WSGR Medical Device Conference in San Francisco, where they will be showcased to investors and compete for the $25,000 Vision Award. The program culminates in The MedTech Conference powered by AdvaMed, Oct. 9-11, in Anaheim, Calif., where five companies will advance to the Grand Finals.

About the American Society of Plastic Surgeons

The American Society of Plastic Surgeons (ASPS) is the largest organization of board-certified plastic surgeons in the world. Representing more than 7,000 physician members, the society is recognized as a leading authority and information source on cosmetic and reconstructive plastic surgery. ASPS comprises more than 92 percent of all board-certified plastic surgeons in the United States. Founded in 1931, the society represents physicians certified by The American Board of Plastic Surgery or The Royal College of Physicians and Surgeons of Canada.

About MedTech Innovator

Based in Los Angeles, MedTech Innovator is the world’s largest accelerator of medical technology companies and the premier nonprofit startup accelerator in the medical technology industry. Its mission is to improve the lives of patients by accelerating the growth of companies that are transforming the healthcare system. In collaboration with 35 corporate partners, as well as a broader network of more than 1,000 industry executives including investors, business development representatives, and other stakeholders, MedTech Innovator provides startups with individualized mentorship and feedback, funding opportunities, and continual engagement with peers and advisors.

For more information about MedTech Innovator, visit https://medtechinnovator.org/ and follow @MedTechAwards on Twitter and MedTech Innovator on LinkedIn.

Share article on social media or email:

PredxBio Appoints Dr. Stanley Marks, Chairman of UPMC Hillman Cancer Center, to its Board of Directors, Strengthening Expertise in Oncology and Precision Medicine


I am excited to become a member of the board of directors at PredxBio, a company with immense potential to revolutionize biomarker discovery and clinical research through its advanced spatial biology analytics.-Dr. Stanley Marks

PredxBio, the industry leader in Spatial Biology and Explainable AI for predicting disease progression, is pleased to announce the addition of Dr. Stanley Marks, Chairman of UPMC Hillman Cancer Center, to its Board of Directors.

“We are thrilled and privileged to welcome Dr. Marks as a distinguished member of PredxBio’s board of directors,” expressed Dusty Majumdar, PhD, CEO of PredxBio. “As a highly regarded pioneer in the field of oncology with extensive experience and a demonstrated history of visionary leadership in cancer care, Dr. Marks brings invaluable insights that will greatly contribute to our ongoing advancements at PredxBio.”

Dr. Stanley Marks, MD, holds the prestigious position of Chairman of UPMC Hillman Cancer Center, serving as the Chief of the Division of Hematology-Oncology at UPMC Shadyside, and a Clinical Professor of Medicine at the University of Pittsburgh. Dr. Marks was also honored by UPMC and his medical partners at Oncology Hematology Association (OHA) through the establishment of the Stanley M. Marks – OHA Endowed Chair in Hematology/Oncology Leadership. With a remarkable career in cancer research, Dr. Marks has held key leadership roles such as President of The Leukemia & Lymphoma Society and has been a member of the board of directors of the American Cancer Society, among others. Recognized as one of the “Best Cancer Doctors in America,” Dr. Marks is a highly respected clinician and a passionate advocate for patients. His impact is evident through the establishment of the Dr. Stanley Marks Research Endowed fund at the Hillman Cancer Center, which has raised an impressive $18 million for cancer research to date.

“I am excited to become a member of the board of directors at PredxBio, a company with immense potential to revolutionize biomarker discovery and clinical research through its advanced spatial biology analytics,” commented Dr. Marks. “PredxBio’s cutting-edge solutions offer scientists in the biopharma and health systems the ability to gain comprehensive and deep insights into the organization and interactions of cells within the tissue microenvironment. PredxBio’s promising results in understanding of disease progression and treatment response to immunotherapy demonstrate the transformative power of this technology.”

Welcoming Dr. Marks to PredxBio’s board of directors, D. Lansing Taylor, PhD, Chairman of the Board at PredxBio and Director at the University of Pittsburgh Drug Discovery Institute (UPDDI), remarked, “Dr. Mark’s deep experience in oncology and his leadership will be invaluable to PredxBio as we grow our business and pursue our mission to leverage the power of spatial biology with Explainable AI and unbiased spatial analytics in delivering innovative therapies that will positively impact the lives of patients.”

The PredxBio platform seamlessly integrates multimodal data, such as spatial proteomics, spatial transcriptomics, and brightfield pathology, to uncover the hidden circuitries of tumor microenvironments and reveal the complex network biology of cancer. By performing highly scalable, Explainable AI (xAI) powered spatial analyses of diverse imaging techniques, PredxBio generates actionable insights for biomarker discovery, identifying drug targets, and designing effective clinical trials. Through the quantification of cell-cell interactions, identification of intermediate cell types and states, and discovery of microdomains, PredxBio delves into the organizing principles of spatial intratumor heterogeneity, providing a mechanistic understanding of tumor initiation, progression, and response to therapy. This comprehensive platform drives personalized therapeutic options, improving prediction accuracies based on spatial tumor biology and enabling optimal treatment selection for individual patients. With the launch of the PredxBio platform, we established our leadership position in Spatial Biology, uniquely capable of predicting patient outcomes with 90%+ accuracy by unraveling the hidden biological circuitries of cancer.

About PredxBio

PredxBio is a Pittsburgh, PA-based company focused on the development of explainable AI-powered spatial analytics software platforms to decipher the complex cancer biology and bend the survival curve for immunotherapy cancer patients. PredxBio’s solutions empower clinicians/researchers to accelerate drug discovery, optimize clinical trials, advance companion diagnostics, personalize therapeutic options, and improve clinical workflows. PredxBio has already completed engagements with early paying customers including pharma partners who are harnessing PredxBio’s solutions to assess treatment response in immunotherapy.

http://www.predxbio.com

Share article on social media or email:

The Exceptional Women Alliance (EWA) announces selection of Dr. Meghan McGovern, Owner and Plastic & Reconstructive Surgeon, RenewalMD, as a 2023 Awardee


Meghan McGovern, Owner and Plastic & Reconstructive Surgeon, RenewalMD

Meghan McGovern, Owner and Plastic & Reconstructive Surgeon, RenewalMD

“We welcome Meghan to EWA! She is a seasoned and well accomplished professional in the very technical field of surgery who has a humane, caring and mission focused approach to making her patients healthier and happier,” said Larraine Segil, Chair and CEO of EWA.

The Exceptional Women Alliance (EWA) announces the selection of Winter 2023 awardee, Dr. Meghan McGovern, Owner and Plastic & Reconstructive Surgeon at RenewalMD. She is trained and educated in the classical tradition and earned her Doctor of Medicine degree at the University of Virginia School of Medicine. She then spent the next six years engaged in surgical training at Lehigh Valley Hospital in Allentown, Pennsylvania. She completed the combined program in General Surgery and Plastic and Reconstructive Surgery.

“We welcome Meghan to EWA! She is a seasoned and well accomplished professional in the very technical field of surgery who has a humane, caring and mission focused approach to making her patients healthier and happier,” said Larraine Segil, Chair and CEO of EWA. “Her tenure as a surgeon and as a leader who has developed an informative, supportive staff that prides itself in providing a superior experience to their patients, brings a unique perspective to our organization. We look forward to her contributions to our growing network of women!”

“I am honored to have been selected to EWA and am inspired daily by the successful women in our network. I find there are so many synergies between the mission of EWA and the people that I serve who want to feel like they are presenting their best selves to the world. I am grateful for the opportunity to learn, share and succeed with my EWA peers and take that into my daily life of helping my clients achieve their goals,” said Dr. McGovern.

Dr. McGovern is certified by the American Board of Plastic Surgery. She is also a fellow of the American College of Surgeons. She was awarded a patent from the United States Patent and Trademark Office for her unique dermal filler technique.

The Exceptional Women Alliance (EWA) is an invitation only peer mentorship organization where high-potential, high-level Exceptional Women from across multiple industries are hand-selected and invested in, to grow, learn, share, and succeed. In addition to the achievement of significant success, the criteria for acceptance include character traits that are defining of the EWA Culture – Kindness, the Spirit of Generosity, Transparency, Gratitude and Willingness to Share their Networks. The Foundation is a powerhouse of peer-to-peer mentoring that provides guidance, deep connection, and leadership, propelling each woman to sustainable success – one woman at a time. The year-long program enables each member to be connected as alumnae for life in the ever-expanding EWA global network, as their fellow women leaders continue to move into positions of significance. Learn more at https://www.exceptionalwomenalliance.com/

Share article on social media or email:

Houston ER Doctor Advises Heat safety as Texas Summer Temperatures Set to Soar


SignatureCare Emergency Center, College Station, TX

SignatureCare Emergency Center, College Station, TX

Symptoms of heat exhaustion and heat stroke include nausea, vomiting and excessive sweating but sometimes it is possible to be out in the heat and facing heat exhaustion, and not be aware of it because you are feeling cool.

Every year from late June to August, temperatures in Texas cities like Houston, Austin, Paris, Killeen, Odessa, Midland, College Station, and Texarkana rise to near triple digits, bringing with it heat-related illnesses such as heat stroke and heat exhaustion.

Even though this is a yearly occurrence, Dr. Christopher Langan, a board-certified Houston, TX emergency room physician and Chief Operating Officer of SignatureCare Emergency Center said it still manages to catch many Texans unprepared.

Texans love their lawns and keeping it looking gorgeous is a thing of pride, but outdoor activities like mowing the lawn and physical exercise often contribute to increase in heat strokes and heat exhaustions.

“Symptoms of heat exhaustion and heat stroke include nausea, vomiting and excessive sweating but sometimes it is possible to be out in the heat and facing heat exhaustion, and not be aware of it because you are feeling cool,” Dr. Langan said.

The ER doctor cautioned Texans to be mindful of these symptoms and listen to their bodies if they are going to be outside as temperatures soar.

“During a heat stroke, your body functions might start to shut down and may fail to adequately compensate for the heat. So instead of sweating as is normal to do when you are out in the heat, you might stop sweating. You could also experience headache and loss of consciousness,” he said.

“If you plan to spend any time outdoors during the summer in Texas, you need to take some precautions,” Dr. Langan added.

He said that during this time of year, emergency rooms see an increase in the number of patients suffering heat exposure.

“Every year we advise the same thing – if you must be outside during rising temperatures, do so early in the morning or later in the evening when the temperature is not so high.

“Mow your lawns in the morning or late evening when the temperature is moderating. Don’t overestimate your body’s ability to compensate for the excessive heat. You do not need to put yourself in harm’s way,” Langan said.

SignatureCare Emergency Center’s emergency rooms in Texas are open 24 hours and board-certified ER physicians are always available onsite.

About SignatureCare Emergency Center

Houston, TX-based SignatureCare Emergency Center owns 24-hour emergency centers throughout Texas, including Atascocita/Humble, Killeen, Austin, College Station/Bryan, Paris, Midland, Odessa, Texarkana, Spring, and Lewisville, TX. We also have nine ER locations in the Houston area, including in Montrose, Houston Heights, Cypress/FM 1960, Copperfield, Memorial City, Westchase, Bellaire, Mission Bend/Sugar Land, and Stafford.

Share article on social media or email:

Comagine Health Names Emily Transue Chief Clinical Officer


Dr. Transue is a well-known and widely respected physician who has spent her career improving the health of the people in her community. I have no doubt she’ll make an incredible impact at Comagine Health.

Comagine Health, a leading national, nonprofit health care consulting firm, announced that Emily R. Transue, MD, MHA, FACP, joined the company as chief clinical officer. Dr. Transue brings more than 20 years of clinical experience and has expertise in primary care, physician-owned multispecialty group leadership, Medicaid managed care and state public benefit programs, including Medicaid and public and school employee benefits.

Before joining Comagine Health, Dr. Transue served as a medical director at the Washington State Health Care Authority (HCA). During her tenure, she provided clinical leadership and oversight of all Public Employees Benefits Board (PEBB) and School Employees Benefits Board (SEBB) programs, including HCA’s Accountable Care Program and Centers of Excellence Program. In addition, she supported the initial years of the Medicaid Transformation Project and provided ongoing leadership of quality measurement and improvement efforts across both Medicaid and the PEBB and SEBB programs.

In her new role as chief clinical officer, Dr. Transue will partner with health care organizations across the country to identify strategies and implement innovations to help them improve the quality and reduce the cost of care for complex patient populations.

“We are thrilled to welcome Dr. Transue to Comagine Health,” said president and CEO Marc Bennett. “She is a well-known and widely respected physician who has spent her career improving the health of the people in her community. I have no doubt she’ll make an incredible impact at Comagine Health.”

Learn more about Dr. Transue and Comagine Health’s leadership team at comagine.org.

###

About Comagine Health

Comagine Health works collaboratively with patients, providers, payers and other stakeholders to reimagine, redesign and implement sustainable improvements in the health care system. As a trusted, neutral party, we work in our communities to address key, complex health and health care delivery problems. In all our engagements and initiatives, we draw upon our expertise in quality improvement, care management, health information technology, analytics and research. We invite our partners and communities to work with us to improve health and redesign the health care delivery system. For more information, please visit comagine.org.

Share article on social media or email:

Perfect Father’s Day gifts giving him the gift of health


Urologist and Prostate Cancer Surgeon, Dr. David Samadi, wishes all dads a Happy and Healthy Father’s Day

Chances are, Dad doesn’t need another tie. Why not give him the gift of good health by encouraging healthy habits keeping him an active part of the family for years to come.

It’s that time of year to celebrate and honor the first man in your life – your dad. Worldwide, the third Sunday in June is Father’s Day, a day set aside to recognize fathers and father figures’ contributions to shaping their children’s lives.

This year, make Dad feel extra special by giving him the gift of good health. Dads often need encouragement and a nudge in the right direction to help them live longer and healthier lives.

Dads work hard in all they do and deserve a gift that keeps giving year-round. Focusing on his health is a perfect way to gift him something that can make him feel physically or mentally better.

Here are inspiring ideas to motivate your dad to lead a little healthier lifestyle so he’ll be around for many more Father’s Days in the future:

Long, exhausting work days are stressful. That’s why dads will need some way to unwind and decompress. Give Dad the gift of relaxation. Why not a hammock? Set it up in the backyard, and he will have hours of taking a siesta after a taxing day at work. A gift certificate for a massage is a thoughtful way for improving dad’s mental health, for boosting his immune system, and for soothing aches and pains after spending hours working.

  • For the dad wanting to improve his athleticism

Men appreciate fitness gifts, especially the dad who loves athletics. Does Dad love tennis? Gift him a new racket. Is he a basketball fanatic? Set up a basketball hoop in the driveway. Does he already workout? Buy him a new pair of gym shoes and workout clothes. Is he wanting to build muscle mass? Consider gifting Dad a workout bench, dumbbells, or a punching bag for improving both cardio and strength, or even a gift certificate with a personal trainer. And for the Dad, who loves honing his athletic skills outdoors, throw in sunscreen to reduce his risk of skin cancer.

  • For dads celebrating their first Father’s Day

New dad’s celebrating Father’s Day for the first time is always exciting. There’s a good chance what a new dad craves most is rest and relaxation. Becoming a new dad is stressful – why not consider giving him a yoga mat. Yoga poses are designed to reduce stress, improve flexibility, and helps ease lower back pains from carrying his new bundle of joy. Or enlist the grandparents to babysit for an evening or overnight so you both can enjoy a date night and get in some extra zzz’s by sleeping in late once.

  • For the dad who loves to cook

If Dad loves to cook, there are numerous ideas for showing your appreciation for this skill. For instance, most men love to grill. There are a variety of gifts to accompany grilling, such as cooking utensils, cookbooks on healthy grilling, a nice set of skewers for shrimp or vegetable kebobs, or, if your budget allows, a brand-new grill. Or consider taking Dad out for a heart-healthy meal at a restaurant specializing in locally grown foods or offers Mediterranean food.

  • For the dad watching his weight

First, congratulate him on wanting to achieve and maintain a healthy body weight. Then look into a weight scale that measures not only his weight but also his percent body fat and body mass index. Pedometers are great for encouraging Dad to walk farther each day or perhaps a membership to a gym or lessons with a personal trainer would be much appreciated. Jump ropes are ideal for burning extra calories while strengthening his bones. To maintain muscle mass while losing weight, a new set of dumbbells to lift will do the trick.

Other healthy gift ideas to consider:

  • Sunglasses with both UVA and UVB protection for his eyes.
  • For dads who travel a lot, consider a sound machine that combines a travel alarm with noise effects, such as helping him fall asleep to wind chimes or a waterfall.
  • Take Dad on a nature hike, kayaking together, fishing, or anything else that helps him relax and have fun.
  • Most importantly, tell Dad how much he is appreciated and loved by telling him so and spending time with him. When a dad realizes his positive impact on your life, this improves his self-confidence and self-worth, making it all the more worthwhile to be your dad.

Dr. David Samadi is the Director of Men’s Health and Urologic Oncology at St. Francis Hospital in Long Island. He’s a renowned and highly successful board certified Urologic Oncologist Expert and Robotic Surgeon in New York City, regarded as one of the leading prostate surgeons in the U.S., with a vast expertise in prostate cancer treatment and Robotic-Assisted Laparoscopic Prostatectomy. Dr. Samadi is also the author of The Ultimate MANual, Dr. Samadi’s Guide to Men’s Health and Wellness, available online both on Amazon and Barnes & Noble. Visit Dr. Samadi’s websites at robotic oncology and prostate cancer 911.

Share article on social media or email:

Revolutionizing Prefilled Injectables through Innovative Technology, Upcoming Webinar Hosted by Xtalks


News Image

In this webinar, a case study will be presented that showcases the advancement of product design based on customer needs, especially in the context of injectables.

As the demand for parenteral products increases, companies are seeking solutions that offer the benefits of prefilled formats while reducing lead times and costs associated with sterile fill-finish services. The projected growth of sterile injectables in the next decade makes finding such solutions crucial. The integration of innovative technology, aseptic manufacturing, and injection molding presents a supply chain that is both flexible and resilient, even during global crises such as the COVID-19 pandemic.

In this webinar, a case study will be presented that showcases the advancement of product design based on customer needs, especially in the context of injectables. The study will demonstrate the progression from using multi-dose glass vials to single-dose prefilled injectors, and how this evolution aligns with the future of technology being in plastic. The speakers will emphasize the logical progression with a focus on integrating quality, convenience, and safety into innovative technology. The FDA has outlined key considerations for transitioning to innovative combination products which will also be discussed. By following a well thought out device development approach, a modular and customizable design can be achieved, offering endless possibilities for creating the appropriate drug delivery solution.

Register for this webinar to learn how scalable fill-finish, a compact supply chain and cost-efficient manufacturing can solve drug delivery challenges for prefilled injectables.

Join experts from ApiJect Systems, Corp., Tony Wasilewski, VP Pharmaceutical Development Services; and Lauren Greenberg, VP Device Development, for the live webinar on Thursday, June 29, 2023, at 11am EDT (4pm BST/UK).

For more information, or to register for this event, visit Revolutionizing Prefilled Injectables through Innovative Technology.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Contact:

Vera Kovacevic

Tel: +1 (416) 977-6555 x371

Email: vkovacevic@xtalks.com

Share article on social media or email:

Webinar: Unveiling the Truth on Upcoding


Photo of Dr. Menen

Michael J. Menen, MD, FACC

Mistakes in medical billing are surprisingly common, and while some are the result of unconscious human error, others, unfortunately, are a deliberate attempt to secure higher reimbursement.

MedReview’s Chief Medical Officer Michael Menen, MD, will present the webinar “Upcoding, a common medical fraud exposed,” on Tuesday, June 20, at 1 pm ET. Co-presented by MedReview and the National Health Care Anti-Fraud Association (NHCAA), the webinar explores how the unethical medical billing practice of upcoding leads to increased costs and decreased accessibility to affordable healthcare. Menen will also discuss strategies to combat upcoding, and the value of clinical validation to uncover fraudulent billing.

Providers are incentivized to maximize revenue by charging the highest possible rates for a particular condition or procedure. Upcoding is a practice that inflates the complexity or severity of a patient’s condition so that providers obtain higher reimbursements from insurance companies or government programs (e.g., Medicare and Medicaid). Upcoding not only defrauds these organizations, but also leads to increased costs for patients via higher insurance premiums, making healthcare financially inaccessible.

“Mistakes in medical billing are surprisingly common, and while some are the result of unconscious human error, others, unfortunately, are a deliberate attempt to secure higher reimbursement,” says Dr. Menen. “As medical claims become more complex, clinical validation is the most thorough way to assess a suspicious claim and uncover upcoding practices.”

As CMO at MedReview, Dr. Menen provides clinical direction on behalf of the organization, develops innovative programs and strategic partnerships, and is ultimately responsible for ensuring payment integrity programs are compliant and clinically accurate – and that MedReview’s findings hold at appeal. Prior to joining MedReview, Dr. Menen was the CMO at Optum Health and UnitedHealthcare.

MedReview offers healthcare payors innovative, physician-led payment integrity solutions to help fight healthcare fraud, waste, and abuse. The company’s clinically driven approach to DRG coding and claims reviews saved clients $351 million in 2022.

Register for the webinar: https://attendee.gotowebinar.com/register/4642681682453754718

About MedReview

Headquartered in the financial district of New York City and serving all U.S. states and territories, MedReview has been a leading provider of payment integrity, utilization management and quality surveillance services for more than 40 years. A physician-led organization with a passion for ensuring that health care claims fairly represent the care provided, MedReview provides timely independent hospital billing audits and clinical validation reviews on behalf of health plans, government agencies and Taft-Hartley organizations, saving millions of dollars for its clients each year.

Share article on social media or email:

Dr. Rob S.B. Beanlands Will Present Keynote Lecture at ASNC2023


Rob S.B. Beanlands, MD, MASNC

Rob S.B. Beanlands, MD, MASNC

“We are at a critical time point in imaging – and in nuclear cardiology in particular – where we need to be striving for the best evidence. This will guide us to really understand how to use imaging to move practice forward for the best possible outcomes for patients.” Dr. Rob Beanlands

Rob S.B. Beanlands, MD, MASNC, deputy director general of the University of Ottawa Heart Institute and internationally acclaimed cardiovascular investigator, will deliver the Mario Verani Memorial Lecture at the American Society of Nuclear Cardiology (ASNC) 2023 Annual Scientific Session and Exhibition. Dr. Beanlands plans to ask the community of cardiac imagers to do some serious “soul searching” about voids in the research that physicians rely on when making clinical decisions that impact the diagnosis and treatment of heart patients.

Randomized clinical trials are the highest level of evidence but are difficult to conduct in imaging since imaging is not directly linked to outcomes. Dr. Beanlands’ ASNC2023 lecture, titled “Imaging Trials and Tribulations – Do We Hibernate, Go With the Flow, or Light the Flame?”, will review the challenges for cardiac imaging trials and how they can be conducted to provide findings that can be implemented in real-world patient care.

“We are at a critical time point in imaging – and in nuclear cardiology in particular – where we need to be striving for the best evidence. This will guide us to really understand how to use imaging to move practice forward for the best possible outcomes for patients,” Dr. Beanlands says.

Dr. Beanlands’ lecture title includes a nod to three exciting areas where nuclear cardiology has had impact and/or is rapidly advancing: myocardial viability, quantification of myocardial blood flow, and inflammation. His research in these and other areas has led to pioneering translational work that has impacted the field’s understanding of disease, application in patient care, health policy, and guidelines. He has led or co-led numerous multicenter imaging research initiatives, including PARR2, IMAGE-Heart Failure, CAIN, CADENCE, and CHASM.

At the University of Ottawa, Dr. Beanlands is the Distinguished Chair of Cardiovascular Imaging and a professor in the Division of Cardiology as well as the Department of Radiology and the Department of Cellular and Molecular Medicine. From 2012 to 2022, he served as chair and chief of the University of Ottawa Heart Institute’s cardiology division. He is also the founding director of the National Cardiac Centre, which is the first PET facility in Canada dedicated to cardiovascular disease.

A past president of both ASNC and the Canadian Nuclear Cardiology Society (CSNCCT), Dr. Beanlands has received numerous awards for his achievements as a researcher, educator and clinician. Recent awards include the Queen Elizabeth II Diamond Jubilee Medal for contributions to Canada; Career Achievement Awards from the CSNCCT and the Canadian Cardiovascular Society (CCS); Research Achievement Awards from the Society of Nuclear Medicine and the CCS; and the CCS/Canadian Institutes of Health Research Distinguished Lecturer Award.

About ASNC2023

The ASNC2023 Main Program will convene Sept. 29 – Oct. 1, at The Westin Harbour Castle in Toronto, Ontario, Canada. Dr. Beanlands will present the Mario Verani Memorial Lecture during the Opening Plenary Session on Friday, Sept. 29, at 8:00 AM (Eastern Time). Attendees may choose in-person or virtual registration.

To attend ASNC2023 educational sessions as a member of the press or to arrange interviews with faculty or other experts, contact Jennifer Taylor Howell at jhowell@asnc.org.

###

About the American Society of Nuclear Cardiology

For 30 years, the American Society of Nuclear Cardiology and its more than 4,900 members have been improving cardiovascular outcomes through image-guided patient management. As the only society dedicated solely to the field of nuclear cardiology, ASNC establishes standards for excellence in cardiovascular imaging through the development of clinical guidelines, professional medical education, advocacy and research development. ASNC provides peer-reviewed original articles through its official publication, The Journal of Nuclear Cardiology. For more information, visit http://www.asnc.org.

Share article on social media or email: